6 terminated. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Terminated 6 |
| Phase 2 | 2 | Terminated 2 |
Follow Osteoporosis: new trials by email Literature Review of Osteoporosis trials Research Report on Osteoporosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women Blosozumab, Placebo - Osteoporosis, Postmenopausal | Phase 1 | Terminated | Eli Lilly and Company | 28 | 2015-01-01 | 2019-01-22 |
| A Study of Odanacatib When Administered to Adolescents and Young Adults Treated With Glucocorticoids (MK-0822-066) Odanacatib, Placebo - Osteoporosis | Phase 1 | Terminated | Merck Sharp & Dohme LLC | 19 | 2013-03-12 | 2018-08-28 |
| Effects of Denosumab on the Pharmacokinetics of Etanercept Etanercept, Denosumab - Postmenopausal, Osteopenia | Phase 1 | Terminated | Amgen | 19 | 2011-03-01 | 2017-06-20 |
| Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women CEP-37251, Placebo - Bone Loss, Osteoporosis | Phase 1 | Terminated | Cephalon | 2 | 2010-07-01 | 2014-05-12 |
| An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass Apomine - Osteoporosis | Phase 1 / Phase 2 | Terminated | Genzyme, a Sanofi Company | 60 | 2003-08-01 | 2014-02-05 |
| Prevention of Steroid-Induced Osteoporosis in Children Pamidronate - Osteoporosis | Phase 1 / Phase 2 | Terminated | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 40 | 2007-12-19 |
Bone Diseases, Metabolic (2) · Arthritis (1) · Arthritis, Rheumatoid (1) · Osteoporosis, Postmenopausal (1)
Bone Diseases (6) · Metabolic Diseases (6) · Musculoskeletal Diseases (6) · Nutritional and Metabolic Diseases (6) · Bone Diseases, Metabolic (4) · Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Joint Diseases (1) · Rheumatic Diseases (1) · Skin and Connective Tissue Diseases (1)
Denosumab (1) · Etanercept (1) · Pamidronate (1) · apomine (1) · blosozumab (1) · odanacatib (1)
Amgen (1) · Cephalon (1) · Eli Lilly and Company (1) · Genzyme, a Sanofi Company (1) · Merck Sharp & Dohme LLC (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)
United States (4) · Australia (1)